Alcohol Septal Ablation of Hyperthropic Obstructive Cardiomyopathy Patient with Respiratory Failure
Hypertrophic Obstructive Cardiomyopathy (HOCM) prevalence is about 1 among 500 population. It is caused by genetic malformation. Dyspnoe, angina pectoris and syncope are clinical manisfestation. Pharmacological and non-pharmacological treatments can be performed to relieve the obstructive symptoms....
Main Authors: | Jusuf Endang, H Haryadi, Siska Suridanda, Andika S, Roy Christian, I Irmalita, Sunu Budi Raharjo, Yoga Yuniadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2013-10-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | http://ijconline.id/index.php/ijc/article/view/304 |
Similar Items
-
A Case Report of Percutaneous Transluminal Septal Myocardial Ablation in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Hasan Namazi, et al.
Published: (2004-12-01) -
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety
by: J Veselka
Published: (2007-12-01) -
Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017-01-01) -
Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
by: Victor Arévalos, et al.
Published: (2021-05-01) -
How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
by: Brandon M. Jones, et al.
Published: (2017-05-01)